Lensar (LNSR) Interest Expenses (2019 - 2020)
Lensar (LNSR) reported Interest Expenses of $65000.0 for Q3 2020, down 86.84% year-over-year from $494000.0 in Q4 2019, and down 90.31% quarter-over-quarter from $671000.0 in Q2 2020.
Lensar (LNSR) Interest Expenses (2019 - 2020) Analysis & Trends
Lensar (LNSR) has 2 years of Interest Expenses data on file, last reported at $65000.0 in Q3 2020.
- Interest Expenses for Q3 2020 came in at $65000.0, down 86.84% year-over-year; the trailing twelve-month figure through Jun 2021 was $65000.0 (down 97.2% YoY), and the FY2020 annual result was $1.3 million, down 33.03% from the prior year.
- Interest Expenses fell to $65000.0 in Q3 2020 per LNSR's latest filing, from $671000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $671000.0 in Q2 2020 and troughed at $65000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 174.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 181.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 90.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 96.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -97.17 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 15.10 Mn |
| 10 | Lensar | 70.41 Mn | 70.70 Mn | 6.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 65,000.00 |
| Sep 30, 2020 | 65,000.00 |
| Jun 30, 2020 | 671,000.00 |
| Jun 30, 2020 | 671,000.00 |
| Mar 31, 2020 | 604,000.00 |
| Mar 31, 2020 | 604,000.00 |
| Dec 31, 2019 | 554,000.00 |
| Dec 31, 2019 | 554,000.00 |
| Sep 30, 2019 | 494,000.00 |
| Sep 30, 2019 | 494,000.00 |